应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ABVC ABVC BioPharma, Inc.
交易中 01-08 11:08:50 EST
2.27
-0.04
-1.73%
最高
2.31
最低
2.26
成交量
1.04万
今开
2.30
昨收
2.31
日振幅
2.16%
总市值
5,516万
流通市值
4,889万
总股本
2,430万
成交额
2.38万
换手率
0.05%
流通股本
2,154万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
ADHD用药困局:2300万患者的“药荒”与国产药的突围之战
华夏时报网 · 01-07 21:05
ADHD用药困局:2300万患者的“药荒”与国产药的突围之战
被 ADHD 困扰的不止罗永浩,我想分享几个能帮上忙的 AI 工具
爱范儿 · 01-07 11:30
被 ADHD 困扰的不止罗永浩,我想分享几个能帮上忙的 AI 工具
罗永浩发文称患ADHD:如换药失败或有体能问题,将不再举办大型活动
新浪科技 · 2025-12-31
罗永浩发文称患ADHD:如换药失败或有体能问题,将不再举办大型活动
Abvc Biopharma, Inc.盘中异动 下午盘快速下挫5.63%报2.18美元
市场透视 · 2025-12-31
Abvc Biopharma, Inc.盘中异动 下午盘快速下挫5.63%报2.18美元
Abvc Biopharma, Inc.盘中异动 股价大跌5.18%报2.81美元
市场透视 · 2025-11-05
Abvc Biopharma, Inc.盘中异动 股价大跌5.18%报2.81美元
跳出套路、月入百万,这家公司验证了“AI+声音”的另一种赚钱方式
创业邦 · 2025-10-04
跳出套路、月入百万,这家公司验证了“AI+声音”的另一种赚钱方式
Abvc Biopharma, Inc.盘中异动 快速下挫5.24%报2.71美元
市场透视 · 2025-09-19
Abvc Biopharma, Inc.盘中异动 快速下挫5.24%报2.71美元
艾伯维将收购Gilgamesh新型MDD在研药物bretisilocin
格隆汇 · 2025-08-26
艾伯维将收购Gilgamesh新型MDD在研药物bretisilocin
8月26日艾伯维宣布与Gilgamesh Pharmaceuticals公司宣布达成一项确定性协议将收购其一款用于治疗中
智通财经 · 2025-08-26
8月26日艾伯维宣布与Gilgamesh Pharmaceuticals公司宣布达成一项确定性协议将收购其一款用于治疗中
Abvc Biopharma, Inc.盘中异动 早盘大幅上涨5.55%报2.85美元
市场透视 · 2025-08-11
Abvc Biopharma, Inc.盘中异动 早盘大幅上涨5.55%报2.85美元
Abvc Biopharma, Inc.盘中异动 大幅拉升6.49%
市场透视 · 2025-08-08
Abvc Biopharma, Inc.盘中异动 大幅拉升6.49%
Abvc Biopharma, Inc.盘中异动 下午盘股价大跌5.00%
市场透视 · 2025-08-07
Abvc Biopharma, Inc.盘中异动 下午盘股价大跌5.00%
Abvc Biopharma, Inc.盘中异动 早盘股价大涨5.09%报2.89美元
市场透视 · 2025-08-04
Abvc Biopharma, Inc.盘中异动 早盘股价大涨5.09%报2.89美元
Abvc Biopharma, Inc.盘中异动 大幅拉升5.41%报2.53美元
市场透视 · 2025-08-01
Abvc Biopharma, Inc.盘中异动 大幅拉升5.41%报2.53美元
Abvc Biopharma, Inc.盘中异动 股价大跌5.03%报2.83美元
市场透视 · 2025-07-31
Abvc Biopharma, Inc.盘中异动 股价大跌5.03%报2.83美元
Abvc Biopharma, Inc.盘中异动 股价大涨5.30%报3.18美元
市场透视 · 2025-07-29
Abvc Biopharma, Inc.盘中异动 股价大涨5.30%报3.18美元
Abvc Biopharma, Inc.盘中异动 大幅跳水5.40%
市场透视 · 2025-07-17
Abvc Biopharma, Inc.盘中异动 大幅跳水5.40%
Abvc Biopharma, Inc.盘中异动 早盘股价大涨5.60%报3.77美元
市场透视 · 2025-07-16
Abvc Biopharma, Inc.盘中异动 早盘股价大涨5.60%报3.77美元
Abvc Biopharma, Inc.盘中异动 早盘股价大跌5.41%报3.32美元
市场透视 · 2025-07-15
Abvc Biopharma, Inc.盘中异动 早盘股价大跌5.41%报3.32美元
Abvc Biopharma, Inc.盘中异动 早盘快速下挫5.54%报3.75美元
市场透视 · 2025-07-14
Abvc Biopharma, Inc.盘中异动 早盘快速下挫5.54%报3.75美元
加载更多
公司概况
公司名称:
ABVC BioPharma, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
ABVC BioPharma, Inc.于2002年2月6日根据内华达州法律注册成立。ABVC BioPharma是一家临床阶段的生物制药公司,拥有六种药物和一种在研医疗器械(ABV-1701/Vitargus)。就其药物产品而言,该公司专注于利用其许可技术,在世界著名的研究机构(如斯坦福大学、加州大学旧金山分校和Cedars-Sinai医学中心)通过临床开发过程的第二阶段进行概念验证试验。对于Vitargus,该公司打算在全球各地的不同地点进行临床试验,直至第三阶段。
发行价格:
--
{"stockData":{"symbol":"ABVC","market":"US","secType":"STK","nameCN":"ABVC BioPharma, Inc.","latestPrice":2.27,"timestamp":1767888401553,"preClose":2.31,"halted":0,"volume":10415,"delay":0,"floatShares":21538900,"shares":24301089,"eps":-0.20892826,"marketStatus":"交易中","change":-0.04,"latestTime":"01-08 11:08:50 EST","open":2.3,"high":2.31,"low":2.26,"amount":23823.010625,"amplitude":0.021645,"askPrice":2.28,"askSize":92,"bidPrice":2.25,"bidSize":196,"shortable":3,"etf":0,"ttmEps":-0.20892826,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1767906000000},"marketStatusCode":2,"adr":0,"listingDate":1627963200000,"exchange":"NASDAQ","adjPreClose":2.31,"preHourTrading":{"tag":"盘前","latestPrice":2.35,"preClose":2.31,"latestTime":"08:30 EST","volume":3,"amount":7.050000000000001,"timestamp":1767879037336},"postHourTrading":{"tag":"盘后","latestPrice":2.31,"preClose":2.31,"latestTime":"16:10 EST","volume":5,"amount":11.55,"timestamp":1767820204238},"volumeRatio":0.675422,"impliedVol":0.6621,"impliedVolPercentile":0.3136},"requestUrl":"/m/hq/s/ABVC","defaultTab":"news","newsList":[{"id":"2601803010","title":"ADHD用药困局:2300万患者的“药荒”与国产药的突围之战","url":"https://stock-news.laohu8.com/highlight/detail?id=2601803010","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601803010?lang=zh_cn&edition=full","pubTime":"2026-01-07 21:05","pubTimestamp":1767791109,"startTime":"0","endTime":"0","summary":"2025年末,罗永浩因ADHD(注意缺陷与多动障碍)导致的迟到事件,意外撕开了一个长期被忽视的医疗市场缺口。长期以来,ADHD患者常被贴上“总是迟到、丢三落四、缺乏毅力、难以合作”的负面标签,外界鲜少知晓这些表现实则是患者难以自控的疾病症状。ADHD多起病于儿童期,长期遭受外界指责与批评的患儿,往往深陷自我怀疑的困境。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601073611712548.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601073611712548.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ADHD","BK4139","ABVC"],"gpt_icon":0},{"id":"2601825260","title":"被 ADHD 困扰的不止罗永浩,我想分享几个能帮上忙的 AI 工具","url":"https://stock-news.laohu8.com/highlight/detail?id=2601825260","media":"爱范儿","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601825260?lang=zh_cn&edition=full","pubTime":"2026-01-07 11:30","pubTimestamp":1767756627,"startTime":"0","endTime":"0","summary":"一颗 ADHD 大脑也会出现上述情况,但背后有明确的病理机制。这是 ADHD 的典型症状之一:启动困难。同理,在面对分心、无法专注等情况时,ADHD 也会出现大脑不断发送专注的指令,整个人却无法执行的情况。长久以来,ADHD 被视为一种“病症”,早年间被称为“多动症”。ADHD 需要的是“喂饭”级别的指令,颗粒度要尽可能的精细。考虑到 ADHD 的友友们在做决策这方面也会瞻前顾后,这个可需要注意喔。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8piWSE3npUC","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["ADHD","ABVC","BK4139"],"gpt_icon":0},{"id":"2595749024","title":"罗永浩发文称患ADHD:如换药失败或有体能问题,将不再举办大型活动","url":"https://stock-news.laohu8.com/highlight/detail?id=2595749024","media":"新浪科技","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595749024?lang=zh_cn&edition=full","pubTime":"2025-12-31 09:12","pubTimestamp":1767143520,"startTime":"0","endTime":"0","summary":"新浪科技讯12月31日上午消息,12月31日凌晨,罗永浩在微博发文称长期患有注意缺陷与多动障碍。 罗永浩表示,因为ADHD的关系,他的发布会没有一场是彩排过的,全是没有彩排直接上去硬讲。 罗永浩表示,多年以来,看起来没出大问题的,全是靠体力、经验和时灵时不灵的药物支撑。 罗永浩还提到,“今晚除了愧疚,剩下的部分大都是幸福的。”罗永浩解释称因为返送有问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tech/2025-12-31/doc-inhervyw3825224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","ADHD","ABVC"],"gpt_icon":0},{"id":"2595172727","title":"Abvc Biopharma, Inc.盘中异动 下午盘快速下挫5.63%报2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595172727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595172727?lang=zh_cn&edition=full","pubTime":"2025-12-31 03:45","pubTimestamp":1767123943,"startTime":"0","endTime":"0","summary":"北京时间2025年12月31日03时45分,Abvc Biopharma, Inc.股票出现异动,股价急速跳水5.63%。截至发稿,该股报2.18美元/股,成交量5.355万股,换手率0.22%,振幅7.79%。Abvc Biopharma, Inc.股票所在的生物技术行业中,整体跌幅为0.84%。Abvc Biopharma, Inc.公司简介:ABVC BioPharma Inc 是一家临床阶段生物制药公司,目前正在开发六种药物和一种医疗器械。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025123103454397a0df69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025123103454397a0df69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVC","BK4139"],"gpt_icon":0},{"id":"2581793014","title":"Abvc Biopharma, Inc.盘中异动 股价大跌5.18%报2.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581793014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581793014?lang=zh_cn&edition=full","pubTime":"2025-11-05 03:29","pubTimestamp":1762284546,"startTime":"0","endTime":"0","summary":"北京时间2025年11月05日03时29分,Abvc Biopharma, Inc.股票出现异动,股价快速下挫5.18%。截至发稿,该股报2.81美元/股,成交量4.0383万股,换手率0.17%,振幅7.09%。Abvc Biopharma, Inc.股票所在的生物技术行业中,整体跌幅为0.07%。Abvc Biopharma, Inc.公司简介:ABVC BioPharma Inc 是一家临床阶段生物制药公司,目前正在开发六种药物和一种医疗器械。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110503290794ef2a81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110503290794ef2a81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVC"],"gpt_icon":0},{"id":"2573947326","title":"跳出套路、月入百万,这家公司验证了“AI+声音”的另一种赚钱方式","url":"https://stock-news.laohu8.com/highlight/detail?id=2573947326","media":"创业邦","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573947326?lang=zh_cn&edition=full","pubTime":"2025-10-04 11:07","pubTimestamp":1759547220,"startTime":"0","endTime":"0","summary":"Endel既不做人声,也不做信息媒介的转换,而是靠 AI 实时生成环境音,服务于“人类需要专注”这一目标。Endel 上线于 2018 年,核心功能是依靠 AI 算法生成个性化音频,帮助用户达成专注、放松或入睡等目的。而这也是 Endel 最大的差异点,以“科学”俘获用户的主要手段。Endel自2021年至今的月流水变化。后续亦有推出节日活动、补充新“声景”和增添练习课程的更新,但从流水表现来看,增效不及之前明显。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MjM5OTAzMjc4MA==&mid=2650845197&idx=3&sn=8575dd0c301c3fb8ede71ca326850f12&chksm=bcb99a132c56753a7dee6b3cc0168fbec1cec8555bdf8e495ff9749ac2c2edc2c9bcd1b69213&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK4585","BK4543","BK4551","BK4139","BK4587","BK4023","ABVC","BK4588","BK4528"],"gpt_icon":1},{"id":"2568650742","title":"Abvc Biopharma, Inc.盘中异动 快速下挫5.24%报2.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568650742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568650742?lang=zh_cn&edition=full","pubTime":"2025-09-19 01:44","pubTimestamp":1758217470,"startTime":"0","endTime":"0","summary":"北京时间2025年09月19日01时44分,Abvc Biopharma, Inc.股票出现异动,股价大幅跳水5.24%。Abvc Biopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.40%。其相关个股中,89Bio, Inc.、Adaptimmune Therapeutics Plc、Aptevo Therapeutics Inc.涨幅较大,Aptevo Therapeutics Inc.、Psyence Biomedical Ltd.、Biocardia, Inc.较为活跃,换手率分别为3287.64%、1292.07%、327.93%,振幅较大的相关个股有Adaptimmune Therapeutics Plc、Aptevo Therapeutics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为119.06%、55.32%、53.46%。Abvc Biopharma, Inc.公司简介:ABVC BioPharma Inc 是一家临床阶段生物制药公司,目前正在开发六种药物和一种医疗器械。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919014430979b80c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919014430979b80c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVC"],"gpt_icon":0},{"id":"2562378033","title":"艾伯维将收购Gilgamesh新型MDD在研药物bretisilocin","url":"https://stock-news.laohu8.com/highlight/detail?id=2562378033","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562378033?lang=zh_cn&edition=full","pubTime":"2025-08-26 18:48","pubTimestamp":1756205298,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1612","BK1167","ABVC","01611","BK4218","HT","BK4181","BK4139"],"gpt_icon":0},{"id":"2562875937","title":"8月26日艾伯维宣布与Gilgamesh Pharmaceuticals公司宣布达成一项确定性协议将收购其一款用于治疗中","url":"https://stock-news.laohu8.com/highlight/detail?id=2562875937","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562875937?lang=zh_cn&edition=full","pubTime":"2025-08-26 18:29","pubTimestamp":1756204158,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","ABVC","BK1167","BK4218","HT","01611","BK4181","BK1612"],"gpt_icon":0},{"id":"2558066573","title":"Abvc Biopharma, Inc.盘中异动 早盘大幅上涨5.55%报2.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558066573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558066573?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:45","pubTimestamp":1754919958,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时45分,Abvc Biopharma, Inc.股票出现波动,股价急速拉升5.55%。Abvc Biopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.25%。其相关个股中,Entero Therapeutics Inc.、Equillium, Inc.、Puma Biotechnology Inc涨幅较大,Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.较为活跃,换手率分别为2777.40%、263.49%、82.71%,振幅较大的相关个股有Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.,振幅分别为74.27%、69.75%、20.72%。Abvc Biopharma, Inc.公司简介:ABVC BioPharma Inc 是一家临床阶段生物制药公司,目前正在开发六种药物和一种医疗器械。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811214559a6dfbe6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811214559a6dfbe6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVC"],"gpt_icon":0},{"id":"2557527470","title":"Abvc Biopharma, Inc.盘中异动 大幅拉升6.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557527470","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557527470?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:35","pubTimestamp":1754660151,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时35分,Abvc Biopharma, Inc.股票出现波动,股价急速上涨6.49%。Abvc Biopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.09%。其相关个股中,180 Life Sciences Corp C/Wts 07/11/2025、Bioxcel Therapeutics, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Onconetix, Inc.、Biovie Inc.、Bioxcel Therapeutics, Inc.较为活跃,换手率分别为87.86%、85.61%、68.66%,振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Cognition Therapeutics, Inc.、Bioxcel Therapeutics, Inc.,振幅分别为35.00%、26.50%、18.16%。Abvc Biopharma, Inc.公司简介:ABVC BioPharma Inc 是一家临床阶段生物制药公司,目前正在开发六种药物和一种医疗器械。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080821355194d7ca49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080821355194d7ca49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVC","BK4139"],"gpt_icon":0},{"id":"2557014103","title":"Abvc Biopharma, Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557014103","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557014103?lang=zh_cn&edition=full","pubTime":"2025-08-07 02:40","pubTimestamp":1754505654,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日02时40分,Abvc Biopharma, Inc.股票出现异动,股价大幅下挫5.00%。截至发稿,该股报2.85美元/股,成交量13.5833万股,换手率0.80%,振幅8.46%。Abvc Biopharma, Inc.股票所在的生物技术行业中,整体跌幅为0.19%。Abvc Biopharma, Inc.公司简介:ABVC BioPharma Inc 是一家临床阶段生物制药公司,目前正在开发六种药物和一种医疗器械。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807024054a6d7130b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807024054a6d7130b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVC","BK4139"],"gpt_icon":0},{"id":"2556038387","title":"Abvc Biopharma, Inc.盘中异动 早盘股价大涨5.09%报2.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556038387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556038387?lang=zh_cn&edition=full","pubTime":"2025-08-04 22:16","pubTimestamp":1754316984,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日22时16分,Abvc Biopharma, Inc.股票出现波动,股价快速上涨5.09%。截至发稿,该股报2.89美元/股,成交量4.4039万股,换手率0.26%,振幅5.45%。Abvc Biopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.93%。Abvc Biopharma, Inc.公司简介:ABVC BioPharma Inc 是一家临床阶段生物制药公司,目前正在开发六种药物和一种医疗器械。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804221624a474a238&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804221624a474a238&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVC","BK4139"],"gpt_icon":0},{"id":"2556811930","title":"Abvc Biopharma, Inc.盘中异动 大幅拉升5.41%报2.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556811930","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556811930?lang=zh_cn&edition=full","pubTime":"2025-08-01 21:48","pubTimestamp":1754056106,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日21时48分,Abvc Biopharma, Inc.股票出现异动,股价大幅拉升5.41%。Abvc Biopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.26%。其相关个股中,天境生物、Bioxcel Therapeutics, Inc.、4D Molecular Therapeutics, Inc.涨幅较大,Bioxcel Therapeutics, Inc.、Salarius Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃,换手率分别为921.23%、120.26%、113.63%,振幅较大的相关个股有Neurosense Therapeutics Ltd.、天境生物、Bioxcel Therapeutics, Inc.,振幅分别为29.12%、22.89%、22.14%。Abvc Biopharma, Inc.公司简介:ABVC BioPharma Inc 是一家临床阶段生物制药公司,目前正在开发六种药物和一种医疗器械。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080121482694c90fee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080121482694c90fee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVC"],"gpt_icon":0},{"id":"2555291750","title":"Abvc Biopharma, Inc.盘中异动 股价大跌5.03%报2.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555291750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555291750?lang=zh_cn&edition=full","pubTime":"2025-07-31 03:08","pubTimestamp":1753902503,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日03时08分,Abvc Biopharma, Inc.股票出现波动,股价急速下挫5.03%。截至发稿,该股报2.83美元/股,成交量8.614万股,换手率0.51%,振幅4.40%。Abvc Biopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.15%。Abvc Biopharma, Inc.公司简介:ABVC BioPharma Inc 是一家临床阶段生物制药公司,目前正在开发六种药物和一种医疗器械。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731030823a6ca2160&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731030823a6ca2160&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVC","BK4139"],"gpt_icon":0},{"id":"2555504520","title":"Abvc Biopharma, Inc.盘中异动 股价大涨5.30%报3.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555504520","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555504520?lang=zh_cn&edition=full","pubTime":"2025-07-29 22:17","pubTimestamp":1753798640,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日22时17分,Abvc Biopharma, Inc.股票出现异动,股价快速拉升5.30%。截至发稿,该股报3.18美元/股,成交量4.7399万股,换手率0.28%,振幅5.96%。Abvc Biopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.42%。Abvc Biopharma, Inc.公司简介:ABVC BioPharma Inc 是一家临床阶段生物制药公司,目前正在开发六种药物和一种医疗器械。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729221721a6c80476&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729221721a6c80476&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVC"],"gpt_icon":0},{"id":"2552487409","title":"Abvc Biopharma, Inc.盘中异动 大幅跳水5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552487409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552487409?lang=zh_cn&edition=full","pubTime":"2025-07-17 22:17","pubTimestamp":1752761823,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日22时17分,Abvc Biopharma, Inc.股票出现波动,股价快速下跌5.40%。Abvc Biopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.31%。其相关个股中,Marker Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Windtree Therapeutics, Inc.涨幅较大,Windtree Therapeutics, Inc.、Marker Therapeutics, Inc.、Immuron Limited较为活跃,换手率分别为814.08%、232.33%、186.59%,振幅较大的相关个股有Marker Therapeutics, Inc.、Windtree Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ,振幅分别为148.12%、67.78%、61.18%。Abvc Biopharma, Inc.公司简介:ABVC BioPharma Inc 是一家临床阶段生物制药公司,目前正在开发六种药物和一种医疗器械。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717221703954643dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717221703954643dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVC","BK4139"],"gpt_icon":0},{"id":"2551160125","title":"Abvc Biopharma, Inc.盘中异动 早盘股价大涨5.60%报3.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551160125","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551160125?lang=zh_cn&edition=full","pubTime":"2025-07-16 21:40","pubTimestamp":1752673249,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日21时40分,Abvc Biopharma, Inc.股票出现异动,股价大幅上涨5.60%。截至发稿,该股报3.77美元/股,成交量1.9696万股,换手率0.12%,振幅5.88%。Abvc Biopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.76%。Abvc Biopharma, Inc.公司简介:ABVC BioPharma Inc 是一家临床阶段生物制药公司,目前正在开发六种药物和一种医疗器械。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162140499544ecf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162140499544ecf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVC","BK4139"],"gpt_icon":0},{"id":"2551607551","title":"Abvc Biopharma, Inc.盘中异动 早盘股价大跌5.41%报3.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551607551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551607551?lang=zh_cn&edition=full","pubTime":"2025-07-15 21:40","pubTimestamp":1752586823,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日21时40分,Abvc Biopharma, Inc.股票出现波动,股价快速跳水5.41%。截至发稿,该股报3.32美元/股,成交量6.6335万股,换手率0.39%,振幅7.98%。Abvc Biopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.12%。Abvc Biopharma, Inc.公司简介:ABVC BioPharma Inc 是一家临床阶段生物制药公司,目前正在开发六种药物和一种医疗器械。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715214023a44c8ffd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715214023a44c8ffd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVC","KAIR","KAPA"],"gpt_icon":0},{"id":"2551846191","title":"Abvc Biopharma, Inc.盘中异动 早盘快速下挫5.54%报3.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551846191","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551846191?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:34","pubTimestamp":1752500090,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时34分,Abvc Biopharma, Inc.股票出现异动,股价急速下跌5.54%。Abvc Biopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。其相关个股中,Dare Bioscience, Inc.、Biomx Inc.、Rani Therapeutics Holdings, Inc.涨幅较大,Windtree Therapeutics, Inc.、Dare Bioscience, Inc.、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为1622.55%、360.91%、170.99%,振幅较大的相关个股有Dare Bioscience, Inc.、Biomx Inc.、Rani Therapeutics Holdings, Inc.,振幅分别为70.78%、44.41%、21.09%。Abvc Biopharma, Inc.公司简介:ABVC BioPharma Inc 是一家临床阶段生物制药公司,目前正在开发六种药物和一种医疗器械。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071421345097a5bd4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071421345097a5bd4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVC","BK4007","RANI","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abvcpharma.com","stockEarnings":[{"period":"1week","weight":0.0845},{"period":"1month","weight":0.0896},{"period":"3month","weight":-0.2979},{"period":"6month","weight":-0.4181},{"period":"1year","weight":2.9828},{"period":"ytd","weight":0.0845}],"compareEarnings":[{"period":"1week","weight":0.0112},{"period":"1month","weight":0.0087},{"period":"3month","weight":0.0274},{"period":"6month","weight":0.1058},{"period":"1year","weight":0.1715},{"period":"ytd","weight":0.0112}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ABVC BioPharma, Inc.于2002年2月6日根据内华达州法律注册成立。ABVC BioPharma是一家临床阶段的生物制药公司,拥有六种药物和一种在研医疗器械(ABV-1701/Vitargus)。就其药物产品而言,该公司专注于利用其许可技术,在世界著名的研究机构(如斯坦福大学、加州大学旧金山分校和Cedars-Sinai医学中心)通过临床开发过程的第二阶段进行概念验证试验。对于Vitargus,该公司打算在全球各地的不同地点进行临床试验,直至第三阶段。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.055376},{"month":2,"riseRate":0.142857,"avgChangeRate":-0.015737},{"month":3,"riseRate":0.714286,"avgChangeRate":0.083622},{"month":4,"riseRate":0.285714,"avgChangeRate":0.004516},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.011992},{"month":6,"riseRate":0.285714,"avgChangeRate":1.316596},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.097297},{"month":8,"riseRate":0.5,"avgChangeRate":-0.054488},{"month":9,"riseRate":0.375,"avgChangeRate":-0.065685},{"month":10,"riseRate":0.375,"avgChangeRate":-0.067045},{"month":11,"riseRate":0.625,"avgChangeRate":0.051458},{"month":12,"riseRate":0.5,"avgChangeRate":-0.012195}],"exchange":"NASDAQ","name":"ABVC BioPharma, Inc.","nameEN":"ABVC BioPharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ABVC BioPharma, Inc.(ABVC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ABVC BioPharma, Inc.(ABVC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ABVC BioPharma, Inc.,ABVC,ABVC BioPharma, Inc.股票,ABVC BioPharma, Inc.股票老虎,ABVC BioPharma, Inc.股票老虎国际,ABVC BioPharma, Inc.行情,ABVC BioPharma, Inc.股票行情,ABVC BioPharma, Inc.股价,ABVC BioPharma, Inc.股市,ABVC BioPharma, Inc.股票价格,ABVC BioPharma, Inc.股票交易,ABVC BioPharma, Inc.股票购买,ABVC BioPharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ABVC BioPharma, Inc.(ABVC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ABVC BioPharma, Inc.(ABVC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}